Recce Pharmaceuticals Ltd (ASX:RCE)
Australia flag Australia · Delayed Price · Currency is AUD
0.3600
0.00 (0.00%)
Sep 2, 2026, 12:09 PM AEST

Recce Pharmaceuticals Statistics

Total Valuation

ASX:RCE has a market cap or net worth of AUD 107.81 million. The enterprise value is 105.78 million.

Market Cap107.81M
Enterprise Value 105.78M

Important Dates

The next estimated earnings date is Friday, September 4, 2026.

Earnings Date Sep 4, 2026
Ex-Dividend Date n/a

Share Statistics

ASX:RCE has 299.47 million shares outstanding. The number of shares has increased by 36.61% in one year.

Current Share Class 299.47M
Shares Outstanding 299.47M
Shares Change (YoY) +36.61%
Shares Change (QoQ) +18.03%
Owned by Insiders (%) 23.09%
Owned by Institutions (%) 13.84%
Float 214.43M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 10.85
PB Ratio -6.45
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 10.64
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.44

Current Ratio 0.44
Quick Ratio 0.40
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -0.07
Interest Coverage -8.02

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -79.40%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 170.68%
Weighted Average Cost of Capital (WACC) 7.57%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.95
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -14.29% in the last 52 weeks. The beta is 0.39, so ASX:RCE's price volatility has been lower than the market average.

Beta (5Y) 0.39
52-Week Price Change -14.29%
50-Day Moving Average 0.38
200-Day Moving Average 0.50
Relative Strength Index (RSI) 41.33
Average Volume (20 Days) 66,924

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, ASX:RCE had revenue of AUD 9.94 million and -14.96 million in losses. Loss per share was -0.05.

Revenue9.94M
Gross Profit 1.79M
Operating Income -13.30M
Pretax Income -14.96M
Net Income -14.96M
EBITDA -13.23M
EBIT -13.30M
Loss Per Share -0.05
Full Income Statement

Balance Sheet

The company has 2.69 million in cash and 666,795 in debt, with a net cash position of 2.03 million or 0.01 per share.

Cash & Cash Equivalents 2.69M
Total Debt 666,795
Net Cash 2.03M
Net Cash Per Share 0.01
Equity (Book Value) -16.72M
Book Value Per Share -0.06
Working Capital -9.21M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -9.89 million and capital expenditures -61,967, giving a free cash flow of -9.95 million.

Operating Cash Flow -9.89M
Capital Expenditures -61,967
Depreciation & Amortization 52,410
Net Borrowing 6.67M
Free Cash Flow -9.95M
FCF Per Share -0.03
Full Cash Flow Statement

Margins

Gross margin is 17.99%, with operating and profit margins of -133.84% and -150.53%.

Gross Margin 17.99%
Operating Margin -133.84%
Pretax Margin -150.53%
Profit Margin -150.53%
EBITDA Margin -133.15%
EBIT Margin -133.84%
FCF Margin n/a

Dividends & Yields

ASX:RCE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -36.61%
Shareholder Yield -36.61%
Earnings Yield -13.88%
FCF Yield -9.23%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 3